Skip to main content
Logo

Funding

We have demonstrated that sustained investment in African science holds the potential for strong and long-term impact. We fund game changing ideas and innovations to transform Africa

Funding Opportunities.

6 opportunities available

Deadline:

The first cohort of eight drug discovery scientists was successfully awarded, in June 2019, after a rigorous selection process. This is therefore an invitation to be part of the second next phase of support for the drug discovery call 2020.

Deadline:

This call covers three strands: i) research, ii) science engagement: call to science and health journalists and communicators, and iii) science engagement: call to science advisers.

Deadline:

Eligible innovators can apply for this competitive follow-on transition to scale or scale up grant which will run for a term of up to thirty-six (36) months. We will fund an amount which is commensurate with the scope of work proposed.

Deadline:

Global Effort on COVID-19 (GECO) Health Research is a new cross UK government funding call aiming to support applied health research that will address COVID-19 knowledge gaps. The focus is on understanding the pandemic and mitigating its health impacts in low and middle-income countries (LMIC) contexts. The call prioritises epidemiology, clinical management, infection control and health system responses.

Deadline:

Proposals are invited for short-term projects addressing and mitigating the health, social, economic, cultural and environmental impacts of the COVID-19 outbreak in Low and Middle Income Countries1.

Deadline:

Type of call: Rolling call

Currently, this call for applications can only be accessed by persons already holding a grant or a sub-grant in the DELTAS Africa, Grand Challenges Africa, H3Africa, FLAIR or any other programme of the AAS. 

Other Funding Opportunities

2 opportunities available

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)

Award value – N/A

Deadline – 

The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19).

Link -  Read More

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)

Award value – N/A

Deadline – 

The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19).

Link -  Read More